HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phil Skolnick Selected Research

Antidepressive Agents (Antidepressants)

8/2015Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test.
5/2012Effects of the triple monoamine uptake inhibitor DOV 102,677 on alcohol-motivated responding and antidepressant activity in alcohol-preferring (P) rats.
1/2012Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial.
1/2006Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Phil Skolnick Research Topics

Disease

8Opiate Overdose
01/2024 - 10/2016
5Alcoholism (Alcohol Abuse)
01/2019 - 12/2003
4Substance-Related Disorders (Drug Abuse)
01/2017 - 10/2012
3Pain (Aches)
01/2018 - 06/2007
3Anxiety Disorders (Anxiety Disorder)
04/2010 - 10/2004
2Schizophrenia (Dementia Praecox)
01/2020 - 01/2017
2Ataxia (Dyssynergia)
01/2020 - 10/2004
2Obesity
01/2020 - 03/2008
2Chronic Pain
01/2018 - 06/2007
2Treatment-Resistant Depressive Disorder
08/2015 - 11/2009
2Amnesia (Dissociative Amnesia)
03/2015 - 10/2004
2Dizziness (Lightheadedness)
11/2012 - 04/2010
2Anhedonia
11/2012 - 01/2012
2Major Depressive Disorder (Major Depressive Disorders)
01/2012 - 01/2006
2Parkinson Disease (Parkinson's Disease)
02/2004 - 08/2003
1Respiratory Insufficiency (Respiratory Failure)
03/2024
1Lethargy
01/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Psychomotor Disorders
01/2020
1Hallucinations (Hallucination)
01/2020
1Poisoning
01/2020
1Cocaine-Related Disorders (Cocaine Addiction)
03/2013
1Weight Gain
11/2012
1Binge Drinking
11/2012
1Fatigue
01/2012
1Jaundice (Icterus)
04/2010
1Epilepsy (Aura)
06/2008
1Sleep Initiation and Maintenance Disorders (Insomnia)
06/2008
1Body Weight (Weight, Body)
03/2008
1Visceral Pain
06/2007
1Hyperalgesia
06/2007
1Neuralgia (Stump Neuralgia)
06/2007

Drug/Important Bio-Agent (IBA)

6Opioid Analgesics (Opioids)IBA
03/2024 - 10/2016
5Naloxone (Narcan)FDA LinkGeneric
03/2024 - 10/2016
5nalmefene (Revex)FDA Link
03/2024 - 11/2019
4Antidepressive Agents (Antidepressants)IBA
08/2015 - 01/2006
4BenzodiazepinesIBA
11/2012 - 10/2004
3Narcotic Antagonists (Opioid Antagonists)IBA
07/2023 - 01/2019
3Serotonin (5 Hydroxytryptamine)IBA
01/2021 - 01/2006
31- (3,4- dichlorophenyl)- 3- azabicyclo- (3.1.0)hexane hydrochlorideIBA
11/2012 - 03/2008
3ocinaplonIBA
11/2012 - 06/2008
2Opioid Receptors (Opioid Receptor)IBA
11/2019 - 01/2019
2N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
08/2015 - 11/2009
2Dopamine D3 ReceptorsIBA
08/2014 - 10/2012
2Norepinephrine (Noradrenaline)FDA LinkGeneric
03/2008 - 01/2006
2Dopamine (Intropin)FDA LinkGeneric
03/2008 - 01/2006
2AMPA Receptors (AMPA Receptor)IBA
02/2004 - 08/2003
1Remifentanil (Ultiva)FDA Link
03/2024
1methocinnamoxIBA
01/2021
1Fentanyl (Sublimaze)FDA LinkGeneric
01/2021
1CyclodextrinsIBA
01/2021
1CannabinoidsIBA
01/2020
1Naltrexone (ReVia)FDA LinkGeneric
01/2019
1dodecyl maltopyranosideIBA
01/2019
1SolutionsIBA
01/2018
1AZD8529IBA
01/2017
1metabotropic glutamate receptor 2IBA
01/2017
1Indicators and Reagents (Reagents)IBA
01/2016
1VaccinesIBA
10/2015
1EnzymesIBA
10/2015
1Monoclonal AntibodiesIBA
10/2015
1KetamineFDA LinkGeneric
08/2015
1Clozapine (Clozaril)FDA LinkGeneric
03/2015
1Buspirone (Buspar)FDA LinkGeneric
03/2013
1Dopamine Receptors (Dopamine Receptor)IBA
03/2013
1alpidemIBA
11/2012
1bretazenilIBA
11/2012
17- (1,1- dimethylethyl)- 6- (2- ethyl- 2H- 1,2,4- triazol- 3- ylmethoxy)- 3- (2- fluorophenyl)- 1,2,4- triazolo(4,3- b)pyridazineIBA
11/2012
1Cocaine (Cocaine HCl)IBA
10/2012
1Methamphetamine (Desoxyn)FDA LinkGeneric
10/2012
1DOV 102,677IBA
05/2012
1Anti-Anxiety Agents (Anxiolytics)IBA
04/2010
1Transaminases (Aminotransferases)IBA
04/2010
1N-Methylaspartate (NMDA)IBA
11/2009
1Anesthetics (Anesthetic Agents)IBA
06/2008
1pyrimidineIBA
06/2008
1HexanesIBA
03/2008
1Triglycerides (Triacylglycerol)IBA
03/2008
14-O-carboxymethylascochlorinIBA
03/2008
1Sulpiride (neogama)IBA
06/2007
1quinone (benzoquinone)IBA
06/2007
1Streptozocin (Streptozotocin)FDA Link
06/2007
1bicifadineIBA
06/2007
1Freund's AdjuvantIBA
06/2007
1Phenyl-P adhesion promoting monomerIBA
06/2007
1KaolinIBA
06/2007
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2006
1LY 404187IBA
02/2004
1GABA-A Receptors (GABA(A) Receptor)IBA
12/2003
1gamma-Aminobutyric Acid (GABA)IBA
12/2003
1Carboxylic AcidsIBA
08/2003
1(R)- 4'- (1- fluoro- 1- methyl- 2- (propane- 2- sulfonylamino)- ethyl)- biphenyl- 4- carboxylic acid methylamideIBA
08/2003
1AcidsIBA
08/2003
1diphenyl (biphenyl)IBA
08/2003

Therapy/Procedure

3Therapeutics
10/2016 - 08/2003
1Emergency Treatment
07/2023
1Oral Administration
01/2019
1Drug Therapy (Chemotherapy)
03/2013
1Self Administration (Administration, Self)
10/2012
1Ligation
06/2007